These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 25164220)
1. [Effects of iloprost combined with low dose tadalafil in adult congenital heart disease patients with severe pulmonary arterial hypertension: a single-center, open-label controlled study]. Zhang C; Huang Y; Huang T; Xia C; Huang X; Zhang G; Yao H; Chen J; Chen J; Wu S; Zhuang J Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):474-80. PubMed ID: 25164220 [TBL] [Abstract][Full Text] [Related]
2. [Immediately effects of inhaled aerosolised iloprost in adult patients with severe pulmonary hypertension secondary to congenital heart diseases]. Zhang CJ; Huang YG; Shen JJ; Huang T; Huang WH; Cui YL; Huang XS Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):65-8. PubMed ID: 21418801 [TBL] [Abstract][Full Text] [Related]
3. Effects of low doses of aerosolized iloprost combined with tadalafil in treatment of adult congenital heart disease with severe pulmonary arterial hypertension. Zhang C; Huang Y; Huang T; Xia C; Huang X; Zhang G; Chen J; Chen J; Zhuang J Chin Med J (Engl); 2014; 127(5):975-7. PubMed ID: 24571899 [No Abstract] [Full Text] [Related]
4. Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension. Zhang DZ; Zhu XY; Meng J; Xue HM; Sheng XT; Han XM; Cui CS; Wang QG; Zhang P Int J Cardiol; 2011 Mar; 147(3):433-7. PubMed ID: 20537740 [TBL] [Abstract][Full Text] [Related]
5. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects. Sitbon O; Beghetti M; Petit J; Iserin L; Humbert M; Gressin V; Simonneau G Eur J Clin Invest; 2006 Sep; 36 Suppl 3():25-31. PubMed ID: 16919007 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases]. Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611 [TBL] [Abstract][Full Text] [Related]
7. Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome. D'Alto M; Romeo E; Argiento P; D'Andrea A; Sarubbi B; Correra A; Scognamiglio G; Papa S; Bossone E; CalabrĂ² R; Vizza CD; Russo MG Int J Cardiol; 2013 Apr; 164(3):323-6. PubMed ID: 21802156 [TBL] [Abstract][Full Text] [Related]
8. Comparison of acute hemodynamic effects of aerosolized iloprost and inhaled nitric oxide in adult congenital heart disease with severe pulmonary arterial hypertension. Caojin Z; Yigao H; Tao H; Wenhui H; Chunli X; Xinsheng H Intern Med; 2012; 51(20):2857-62. PubMed ID: 23064558 [TBL] [Abstract][Full Text] [Related]
9. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology. D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; CalabrĂ² R Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of PDE-5 inhibitor tadalafil in pulmonary arterial hypertension. Bharani A; Patel A; Saraf J; Jain A; Mehrotra S; Lunia B Indian Heart J; 2007; 59(4):323-8. PubMed ID: 19126937 [TBL] [Abstract][Full Text] [Related]
11. [The oxygen kinetic effect of inhaled iloprost in pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension]. Cui N; Yang YH; Xie WM; Ma ZH; Luo L; Wang C Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):522-6. PubMed ID: 19954007 [TBL] [Abstract][Full Text] [Related]
12. Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease. Gorenflo M; Gu H; Xu Z Cardiology; 2010; 116(1):10-7. PubMed ID: 20424447 [TBL] [Abstract][Full Text] [Related]
13. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. McLaughlin VV; Oudiz RJ; Frost A; Tapson VF; Murali S; Channick RN; Badesch DB; Barst RJ; Hsu HH; Rubin LJ Am J Respir Crit Care Med; 2006 Dec; 174(11):1257-63. PubMed ID: 16946127 [TBL] [Abstract][Full Text] [Related]
14. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967 [TBL] [Abstract][Full Text] [Related]
15. [Effects of inhaled aerosolized iloprost in adult patients with pulmonary arterial hypertension on right heart functions]. Guo XX; Tian Z; Liu YT; Wang Q; Li MT; Zeng XF; Zhu WL; Fang Q Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2832-6. PubMed ID: 22333544 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease. Benza RL; Rayburn BK; Tallaj JA; Coffey CS; Pinderski LJ; Pamoukian SV; Bourge RC Chest; 2006 Apr; 129(4):1009-15. PubMed ID: 16608951 [TBL] [Abstract][Full Text] [Related]
17. [Aerosolized iloprost therapy for pulmonary hypertensive crisis in 4 patients with idiopathic pulmonary arterial hypertension]. Deng KW; Zhou YJ; Xu XQ; Wu MY; Wang GH; Bian H; Chen B; Wang CB Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct; 40(10):854-7. PubMed ID: 23302674 [TBL] [Abstract][Full Text] [Related]
18. Combination therapy of prostacyclin for pulmonary hypertension in congenital heart disease. Durongpisitkul K; Jakrapanichakul D; Laohaprasitiporn D; Soongswang J; Chanthong P; Nana A J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S60-5. PubMed ID: 16856428 [TBL] [Abstract][Full Text] [Related]
19. Acute responses to inhalation of Iloprost in patients with pulmonary hypertension. Zhang HL; Liu ZH; Wang Y; Xiong CM; Ni XH; He JG; Luo Q; Zhao ZH; Zhao Q; Sun XG Chin Med J (Engl); 2012 Aug; 125(16):2826-31. PubMed ID: 22932074 [TBL] [Abstract][Full Text] [Related]
20. [The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension]. Luo L; Yang YH; Cui N; Xie WM; Zhai ZG; Ma ZH; Wang C Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2103-5. PubMed ID: 20058612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]